Trial intelligence / Profile preview

African Glaucoma Laser Trial

NCT03648229Phase 4Withdrawn

Sponsor
West Virginia University
Start
Sep 2019
Primary completion
Jun 2022
01

Overview

Phase 4, randomised, single-blind trial in open-angle glaucoma (OAG) (3 arms), sponsored by West Virginia University. Primary endpoint: Intraocular Pressure at 12 months. Planned start Sep 2019; status: withdrawn.

02

Conditions

open-angle glaucoma (OAG)

Beyond the preview

Go deeper on NCT03648229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03648229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call